Unknown

Dataset Information

0

Cost-Effectiveness of Antenatal Rescreening Among Pregnant Women for Hepatitis C in the United States.


ABSTRACT: To inform proposed changes in U.S. HCV screening guidelines, we assessed the cost-effectiveness of HCV antenatal rescreening for women without evidence of HCV during a prior pregnancy, using a previously published model. Universal HCV rescreening among pregnant women was cost-effective (ICER $6,000/QALY) and should be recommended nationally.

SUBMITTER: Chaillon A 

PROVIDER: S-EPMC8563211 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7188080 | biostudies-literature
| S-EPMC3638200 | biostudies-other
| S-EPMC3097367 | biostudies-literature
| S-EPMC7561704 | biostudies-literature
| S-EPMC4435698 | biostudies-literature
| S-EPMC2600200 | biostudies-literature
| S-EPMC2669282 | biostudies-literature
| S-EPMC8595618 | biostudies-literature
| S-EPMC9087297 | biostudies-literature
| S-EPMC5928737 | biostudies-other